[Current evaluation of the fluoroquinolones].
Originally, the fluoroquinolones were classified into the groups I-IV on the basis of their clinical field of application, pharmacokinetics, antibacterial spectrum, and bioavailability. In the present publication an evaluation taking account in particular of aspects of clinical application and dosage has been undertaken based on the 1998 classification by a group of PEG experts.
Adam
Dieter
D
Expertenkommission der Infektliga, München. Dieter.Adam@med.uni-muenchen.de
D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004335:Drug and Narcotic Control; D024841:Fluoroquinolones / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011358:Product Surveillance, Postmarketing; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy*; D016896:Treatment Outcome
D024841:Fluoroquinolones